Prevalence and impact of airway diseases on clinical outcomes in idiopathic pulmonary fibrosis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The prevalence and effects of airway diseases, including asthma, eosinophilic bronchitis (EB), chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) have not been thoroughly studied in patients with idiopathic pulmonary fibrosis (IPF). This study aimed to evaluate the prevalence of airway diseases in patients with IPF and to identify the differences in symptoms based on the presence of airway diseases. Methods: This single-institution prospective cohort study was conducted from June 2017 to September 2018, at the Seoul National University Hospital. Spirometry with bronchodilator, methacholine bronchial provocation test, induced sputum with eosinophil stain, and exhaled nitric oxide were performed to confirm the presence of airway disease. The modified Medical Research Council (mMRC) dyspnea scale, COPD assessment test (CAT), St. George’s Respiratory Questionnaire (SGRQ), Euro- Qol-5 dimension (EQ-5D) index, and cough-specific quality of life questionnaire (CQLQ) data were collected to assess symptom severity. Results: Total 147 patients with IPF were screened, and 70 patients were analyzed. The prevalence of airway diseases in the participants was as follows: 5.0% had COPD, 1.7% had asthma, 3.3% had ACO, and 1.7% had EB. The mMRC, CAT, SGRQ, EQ-5D, and CQLQ scores did not differ regardless of combined airway disease. After 3 months, the SGRQ (p = 0.028) and CQLQ (p = 0.030) scores were significantly higher in patients with airway disease than in those without. Conclusions: The prevalence of airway diseases in patients with IPF is low, but when airway diseases are accompanied by IPF, symptom severity and quality of life may worsen rapidly.
Abstract
Background/Aims: The prevalence and effects of airway diseases, including asthma, eosinophilic bronchitis (EB), chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) have not been thoroughly studied in patients with idiopathic pulmonary fibrosis (IPF). This study aimed to evaluate the prevalence of airway diseases in patients with IPF and to identify the differences in symptoms based on the presence of airway diseases. Methods: This single-institution prospective cohort study was conducted from June 2017 to September 2018, at the Seoul National University Hospital. Spirometry with bronchodilator, methacholine bronchial provocation test, induced sputum with eosinophil stain, and exhaled nitric oxide were performed to confirm the presence of airway disease. The modified Medical Research Council (mMRC) dyspnea scale, COPD assessment test (CAT), St. George’s Respiratory Questionnaire (SGRQ), Euro- Qol-5 dimension (EQ-5D) index, and cough-specific quality of life questionnaire (CQLQ) data were collected to assess symptom severity. Results: Total 147 patients with IPF were screened, and 70 patients were analyzed. The prevalence of airway diseases in the participants was as follows: 5.0% had COPD, 1.7% had asthma, 3.3% had ACO, and 1.7% had EB. The mMRC, CAT, SGRQ, EQ-5D, and CQLQ scores did not differ regardless of combined airway disease. After 3 months, the SGRQ (p = 0.028) and CQLQ (p = 0.030) scores were significantly higher in patients with airway disease than in those without. Conclusions: The prevalence of airway diseases in patients with IPF is low, but when airway diseases are accompanied by IPF, symptom severity and quality of life may worsen rapidly.
참고문헌 (20)
- Raghu G, "An official ATS", ERS, ALAT clinical practice guideline : treatment of idiopathic pulmonary fibrosis. An update of the 2011 Clinical Practice Guideline, pp.Am J Respir Crit Care Med, 2015[DOI]
- Raghu G, "An official ATS", ERS, ALAT statement : idiopathic pulmonary fibrosis. Evidence-based guidelines for diagnosis and management, pp.Am J Respir Crit Care Med, 2011[DOI]
- Crystal RG, "Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects", Ann Intern Med, 85, pp.769~788 (1976)
- Shorr AF, "Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant", Eur Respir J, 30, pp.715~721 (2007)
- Ryerson CJ, "Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis", Chest, 144, pp.234~240 (2013)
- Adeloye D, "Global and regional estimates of COPD prevalence : systematic review and meta-analysis", J Glob Health, 5, pp.020415~ (2015)
- To T, "Global asthma prevalence in adults : findings from the cross-sectional world health survey", BMC Public Health, 12, pp.204~ (2012)
- Gibson PG, "Eosinophilic bronchitis : clinical manifestations and implications for treatment", Thorax, 57, pp.178~182 (2002)
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease, "Global Initiative for Chronic Obstructive Lung Disease", GOLD, ~ (2017)
- Global Strategy for Asthma Management and Prevention, "Global Initiative for Asthma", GINA, ~ (2017)
- Dweik RA, "An official ATS clinical practice guideline : interpretation of exhaled nitric oxide levels(FENO)for clinical applications", Am J Respir Crit Care Med, 184, pp.602~615 (2011)
- Chow S, "Exhaled breath condensate(EBC)biomarkers in pulmonary fibrosis", J Breath Res, 6, pp.016004~ (2012)
- Guilleminault L, "Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?", Respir Med, 107, pp.1789~1796 (2013)
- Plantier L, "Physiology of the lung in idiopathic pulmonary fibrosis", Eur Respir Rev, 27, pp.170062~ (2018)
- Pastre J, "Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases", BMC Pulm Med, 15, pp.100~ (2015)
- Lopes AJ, "Correlation of tomographic findings with pulmonary function parameters in nonsmoking patients with idiopathic pulmonary fibrosis", J Bras Pneumol, 33, pp.671~678 (2007)
- Plantier L, "Increased volume of conducting airways in idiopathic pulmonary fibrosis is independent of disease severity : a volumetric capnography study", J Breath Res, 10, pp.016005~ (2016)
- Beeh KM, "Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis", Sarcoidosis Vasc Diffuse Lung Dis, 20, pp.138~143 (2003)
- Schwartz DA, "Determinants of survival in idiopathic pulmonary fibrosis", Am J Respir Crit Care Med, 149(2 Pt 1), pp.450~454 (1994)
- Peterson MW, "Prognostic role of eosinophils in pulmonary fibrosis", Chest, 92, pp.51~56 (1987)